Pluristem Therapeutics In... (PSTI)
NASDAQ: PSTI
· Real-Time Price · USD
1.00
-0.03 (-2.91%)
At close: Jul 26, 2022, 6:00 AM
Pluristem Therapeutics Revenue
Pluristem Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2022, Pluristem Therapeutics generated $234K in revenue.
Revenue (ttm)
0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
0
Employees
153
Market Cap
40.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Jun 30, 2021 | 0 | -100.00% |
| Jun 30, 2020 | 23K | -57.41% |
| Jun 30, 2019 | 54K | +8.00% |
| Jun 30, 2018 | 50K | +Infinity% |
| Jun 30, 2017 | 0 | -100.00% |
| Jun 30, 2016 | 2.85M | +651.19% |
| Jun 30, 2015 | 379K | n/a |
| Jun 30, 2014 | 379K | -44.18% |
| Jun 30, 2013 | 679K | -5.17% |
| Jun 30, 2012 | 716K | +Infinity% |
| Jun 30, 2011 | 0 | n/a |
| Jun 30, 2010 | 0 | n/a |
| Jun 30, 2009 | 0 | n/a |
| Jun 30, 2008 | 0 | n/a |
| Jun 30, 2007 | 0 | n/a |
| Jun 30, 2006 | 0 | n/a |
| Jun 30, 2005 | 0 | n/a |
| Jun 30, 2004 | 0 | n/a |
| Jun 30, 2003 | 0 | n/a |
| Jun 30, 2002 | 0 | n/a |